Giant Cell Arteritis

REFERENCES

• Aiello P D, Trautmann J C, McPhee T J, et al. Visual prognosis in giant cell arteritis. Ophthalmology 1993; 100: 550
   PubMed Web of Science ®Google Scholar
• Alvarez-Lafuente R, Fernandez-Gutierrez B, Jover J A, Judez E, Loza E, Clemente D, Garcia-Asenjo J A, Lamas J R. Human parvovirus B19, varicella zoster virus, and human herpes virus 6 in temporal artery biopsy specimens of patients with giant cell arteritis: analysis with quantitative real time polymerase chain reaction. Ann Rheum Dis 2005; 64: 780–2
   PubMed Web of Science ®Google Scholar
• Andersson R, Jonsson R, Tarkowski A, Bengttsson B A, Malmvall B E. T cell subsets and expression of immunological activation markers in the arterial walls of patients with giant cell arteritis. Ann Rheum Dis 1987; 46: 915–23
   PubMed Web of Science ®Google Scholar
• Appelboom T, van Eigem A. How ancient is temporal arteritis?. J Rheumatol 1990; 17: 929–931
   Google Scholar
• Arashvand K. Benefit of high-dose intravenous methylprednisolone as induction therapy for giant cell arteritis: Comment on the article by Mazlumzadeh et al. Arthritis Rheum 2007; 56(5)1722
   Google Scholar
• Ashton-Key M R, Gallagher P J. False-negative temporal artery biopsy. Amer J Surg Path 1992; 16: 634–5
   PubMed Web of Science ®Google Scholar
• Bengtsson B-A. Epidemiology of giant cell arteritis. Bailliere's Clinical Rheumatology, B L Hazelman, B-A Bengtsson. Bailliere Tindall, London 1991; 380–3
   Google Scholar
• Bharadwaj A, Dasgupta B, Wolfe K, Nordborg C, Nordborg E. Difficulties in the development of histological scoring of the inflamed temporal arteries in giant cell arteritis. Rheumatology 2005; 44: 1579–90
   Google Scholar
• Bhatia A, Ell P J, Edwards C W. Anti-CD20 monoclonal antibody (rituximab) in the treatment of giant cell arteritis. Ann Rheum Dis 2005; 64: 1099–100
   PubMed Web of Science ®Google Scholar
• Bley T A, Weiben O, Uhl M, Vaith P, Schmidt D, Warnatz K, Langer M. Assessment of the cranial involvement pattern of giant cell arteritis with 3T magnetic resonance imaging. Arthritis Rheum 2005; 52(8)2470–7
   PubMed Web of Science ®Google Scholar
• Blockman D, de Ceuninck L, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H. Repetitive 18F-Fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum 2006; 55: 131–7
   Google Scholar
• Boesen P, Sorensen S F. Giant cell arteritis, temporal arteritis and polymyalgia rheumatica in a Danish county. Arthritis Rheum 1987; 30: 292–9
   Google Scholar
• Bylow K A, Brauner D J. Temporal arteritis: The importance of recognizing senescent changes versus quiescent disease in a temporal artery biopsy. Journal of the American Geriatrics Society 2006; 54(12)1959–60
   Google Scholar
• Calamia K T, Hunder G G. Giant cell arteritis (temporal arteritis) presenting as fever of undetermined origin. Arthritis Rheum 1981; 24: 1414
   PubMed Web of Science ®Google Scholar
• Cankovic M, Zarbo R J. Failure to detect human herpes simplex virus, cytomegalovirus, and Epstein-Barr virus viral genomes in giant cell arteritis biopsy specimens by real-time quantitative polynmerase chain reaction. Cardiovasc Pathol 2006; 15(5)280–6
   Google Scholar
• Cantini F, Niccoli L, Storri L, Nannini C, Olivieri I, Padula A, Boiardi L. Salvarani. Are polymyalgia rheumatica and giant cell arteritis the same disease?. Semin Arthritis Rheum 2004; 33: 294–301
   PubMed Web of Science ®Google Scholar
• Caporali R, Cimmino M A, Ferraccioli G, Gerli R, Klersy C, Salvarani C, Monetcucco C. Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 2004; 141: 493–50
   PubMed Web of Science ®Google Scholar
• Caselli R J, Daube J R, Hunder G G, Whisnant J P. Peripheral neuropathic syndromes in giant cell (temporal) arteritis. Neurology 1988; 38: 685–9
   PubMed Web of Science ®Google Scholar
• Chevelat P, Barrier J H, Pottier P, Magadur-Joly G, Pottier M A, Hamidou M, Planchon B, El Kouri D, et al. A randomized, multicenter, controlled trial using intravenous pulses of methylprednisolone in the initial treatment of simple forms of giant cell arteritis: a one year followup study of 164 patients. J Rheumatol 2000; 27(6)1484–91
   Google Scholar
• Chong E T, Robertson A J. Is temporal artery biopsy a worthwhile procedure?. ANZ J Surg 2005; 75: 388–91
   Google Scholar
• Cid M C, Hoffman M P, Hernandez-Rodriguez J, Segarra M, Elkin M, Sanchez M, Vilardell C, Garcia-Martinez A, Pla-Campo M, Grau J M, Kleinman H K. Association between increased CCL2 (MCP-1) expression in lesions and persistence of disease activity in giant-cell arteritis. Rheumatology 2006; 45: 1356–63
   PubMed Web of Science ®Google Scholar
• Cid M C, Cebrian M, Font C, Coll-Vinent B, Hernandez-Rodriguez J, Esparza J, Urbano-Marquez A, Grau J M. Cell adhesion molecules in the development of inflammatory infiltrates in giant cell arteritis: inflammation-induced angiogenesis as the preferential site of leukocyte-endothelial cell interactions. Arthritis Rheum 2000; 43(1)184–94
   Google Scholar
• Cid M C, Font C, Oristrell J, de la Sierra A, Coll-Vinent B, López-Soto A, Vilaseca J, Urbano-Marquez A, Grau J M. Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis. Arthritis Rheum 1998; 41: 26–32
   PubMed Web of Science ®Google Scholar
• Cid M C, Hernandez-Rodriguez J, Esteban M J, Cebrian M, Gho Y S, Font C, Urbano-Marquez A, Grau J M, Kleinman H K. Tissue and serum angiogenic activity is associated with low prevalence of ischemic complications in patients with giant-cell arteritis. Circulation 2002; 106: 1664–71
   PubMed Web of Science ®Google Scholar
• Cikes A, Depairon M, Joidon R M, et al. Necrosis of the tongue and unilateral blindness in temporal arteritis. Vasa 2001; 30: 222–4
   Google Scholar
• Danesh-Meyer H, Savino P J, Eagle R C, Jr., Kubis K C, Sergott R C. Low diagnostic yield with second biopsies in suspected giant cell arteritis. J Neuro-Opthalmol 2000; 20: 213–5
   PubMed Web of Science ®Google Scholar
• Dickson E R, Maldonado J E, Sheps S G, Cain J A, Jr. Systemic giant-cell arteritis with polymyalgia rheumatica: reversible abnormalities of liver function. JAMA 1973; 224(11)1496–8
   Google Scholar
• Donnelly J A, Torregiani S. Polymaylgia Rheumatica and Giant Cell Arteritis. Clinics in Family Practice June, 2005; 7(2)225–247
   Google Scholar
• Drehmer T J, Khanna D, Markert R J, Hawkins R A. Diagnostic and management trends of giant cell arteritis: a physician survey. J Rheumatol 2005; 32(7)1186–8
   Google Scholar
• Evans J M, O'Fallon W M, Hunder G G. Increased incidence of aortic aneurysm and dissection in giant cell(temporal) arteritis. Ann Intern Med 1995; 122: 502–7
   PubMed Web of Science ®Google Scholar
• Ferrara D E, Liu X, Espinola R G, Meroni P L, Abukhalaf I, Harris E N, et al. Inhibition of the thrombogenic and inflammatory properties of antiphospholipid antibodies b fluvastatin in an in vivo animal model. Arthritis Rheum 2003; 48: 3272–9
   PubMed Web of Science ®Google Scholar
• Font R L, Prabhakaran C. Histological parameters helpful in recognizing steroid-treated temporal arteritis: an analysis of 35 cases. Br J Ophthalmol 2007; 91: 204–9
   PubMed Web of Science ®Google Scholar
• Gabriel S E, O'Fallon W M, Achkar A, et al. The use of clinical characteristics to predict the results of temporal artery biopsy among patients with suspected giant cell arteritis. J Rheumatol 1995; 22: 93–6
   PubMed Web of Science ®Google Scholar
• Garcia-Martinez A, Hernandez-Rodriguez J, Grau J M, Cid M C. Treatment with statins does not exhibit a clinically relevant corticosteroid-sparing effect in patients with giant cell arteritis. Arthritis Rheum 2004; 51(4)674–8
   Google Scholar
• Gilmour J R. Giant cell chronic arteritis. J. Pathol Bacteriol 1941; 53: 263–277
   Google Scholar
• Gonzalez-Gay M A, Blanco R, Rodriguez-Valverde V, et al. Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatement. Arthritis Rheum 1998; 41: 1497–1504
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gay M A, Garcia-Porrua C, Miranda-Filloy J A, Martin J. Giant cell arteritis and polymyalgia rheumatica: pathophysiology and management. Drugs & Aging 2006; 23(8)627–49
   Google Scholar
• Gonzalez-Gay M A, Hajeer A H, Dababneh A, Garcia-Porrua C, Amoli M M, Llorca J, Ollier W E. Interferon-gamma gene microsatellite polymorphisms in patients with biopsy-proven giant cell arteritis and isolated polymyalgia rheumatica. Clin Exp Rheumatol 2004; 22: S18–20, (6 Suppl 36)
   PubMed Web of Science ®Google Scholar
• Gonzalez-Juanatey C, Llorca J, Garcia-Porrua C, Sanchez-Andrade A, Martin J, Gonzalez-Gay M A. Steroid therapy improves endothelial function in patients with biopsy-proven giant cell arteritis. J Rheumatol 2006; 33(1)74–8
   Google Scholar
• Gonzalez-Gay M A. Genetic epidemiology giant cell arteritis and polymyalgia rheumatica. Arthritis Res 2001; 3: 154–7
   PubMedGoogle Scholar
• Gonzalez-Gay M A, Lopez-Diaz M J, Barros S, Garcia-Porrua C, Sanchez-Andrade A, Paz-Carreira J, Martin J, Llorca J. Giant cell arteritis: laboratory tests at the time of diagnosis in a series of 240 patients. Medicine (Baltimore) Sep, 2005; 84(5)277–90
   PubMed Web of Science ®Google Scholar
• Gordon L K, Levin L A. Visual loss in giant cell arteritis. JAMA 1998; 280: 385–6
   PubMedGoogle Scholar
• Goronzy J J, Weyand C M, Hunder G G, Mazlumzadeh M. Reply. Arthitis Rheum 2007; 56(5)1723
   Google Scholar
• Grodum E, Petersen H A. Temporal arteritis with normal erythrocyte sedimentation rate. J Intern Med 1990; 227(4)279–80
   Google Scholar
• Hall S, Hunder G G. Is temporal artery biopsy prudent?. Mayo Clin Proc 1984; 59: 793–5
   PubMedGoogle Scholar
• Hall J K, Volpe N J, Galetta S L, Liu G T, Syed N A, Baker L J. The role of unilateral temporal artery biopsy. Ophthalmology 2003; 110: 543–8
   Web of Science ®Google Scholar
• Hayreh S S, Zimmerman B. Visual deterioration in giant cell arteritis patients while on high doses of corticosteroid therapy. Ophthalmology 2003; 110(6)1204–15
   PubMed Web of Science ®Google Scholar
• Hayreh S S, Zimmerman B, Kardon R H. Visual improvement with corticosteroid therapy in giant cell arteritis: report of a large study and review of literature. Acta Ophthalmol Scand 2002; 80: 353–67
   Google Scholar
• Healey A. Relation of giant cell arteritis to polymyalgia rheumatica. Bailliere's clinical rheumatology, B L Hazelman, B-A Bengtsson. Bailliere Tindall, London 1991; 372–3
   Google Scholar
• Healey L A, Wilske K R. Anemia as a presenting manifestation of giant cell arteritis. Arthitis Rheum 1971; 14(1)27–31
   Google Scholar
• Hellman D B, Hunder G G. Giant cell arteritis and polymyalgia rheumatica. Kelley 's Textbook of Rheumatology, 7th ed, Edward D. Harris. Saunders Company, Philadelphia 2005
   Google Scholar
• Hoffman G S, Cid M C, Hellmann D B, Guillevin L, Stone J H, et al. A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum 2002; 46(5)1309–18
   PubMedGoogle Scholar
• Horton B T, Magath T B, Brown G E. An undescribed form of arteritis of the temporal vessels. Proc Staff Meet Mayo Clinic 1932; 7: 700–701
   Google Scholar
• Hunder G G. The early history of giant cell arteritis and polymyalgia rheumatica: first descriptions to 1970. Mayo Clinic Proc 2006; 81(8)1071–1083
   PubMed Web of Science ®Google Scholar
• Hunder GG. Giant cell arteritis and polymyalgia rheumatica. Textbook of Rheumatology, 6th ed, W N Kelly, E D Harris, S Ruddy, et al. WB Saunders Company, Philadelphia 2001
   Google Scholar
• Hunder G G. Giant cell arteritis and polymyalgia rheumatica. Med Clin North Am 1997; 81(1)195–219
   Google Scholar
• Hunder G G, Bloch D A, Michel B A, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990; 33: 1122–9
   PubMed Web of Science ®Google Scholar
• Hutchinson J. Diseases of the arteries. Arch Surg (London) 1889–90; 1: 323
   Google Scholar
• Jover J A, Hernandez-Garcia C, Morado I C, Vargas E, Banares A, Fernandez-Gutierrez B. Combined treatment of giant-cell arteritis with methotrexate and prednisone: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 2001; 134: 106–1
   PubMed Web of Science ®Google Scholar
• Jover J A, Hernandez-Garcia C, Morado I C, Vargas E, Banares A, Fernandez-Gutierrez B. Disparate results in studies of methotrexate plus corticosteroids in the treatment of giant cell arteritis: comment on the article by Hoffman et al. Arthritis Rheum 2003; 48(4)1158–9
   Google Scholar
• Karahaliou M, Vaiopoulos G, Papaspyrou S, Kanakis M A, Revenas K, Sfikakis P P. Colour duplex sonography of temporal arteries before decision for biopsy: a prospective study in 55 patients with suspected giant cell arteritis. Arthritis Res Ther 2006; 8: R116
   PubMed Web of Science ®Google Scholar
• Kathula S K, Mantil J, Drehmer T, Patil S S. Giant cell arteritis mimicking multiple myeloma; diagnosed by PET scan. Southern Med J 2006; 99(11)1280–1
   Google Scholar
• Kyle V, Cawston T E, Hazleman B L. Erythrocyte sedimentation rate and C rective protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up. Ann Rheum Dis 1989; 48(8)667–71
   Google Scholar
• Lam B L, Wirthlin R S, Gonzalez A, Dubovy S R, Feuer W J. Giant cell arteritis among Hispanic Americans. Am J Opthalmol Jan, 2007; 143(1)161–3
   Google Scholar
• Lauwerys B R, Puttemans T, Houssiau F, Devogelaer J P. Color Doppler sonography of the temporal arteries in giant cell arteritis and polymyalgia rheumatica. J Rheumatol 1997; 24: 1570–4
   Google Scholar
• Lee M S, Smith S D, Galor A, Hoffman G S. Antiplatelet and anticoagulant therapy in patients with giant cell arteritis. Arthritis Rheum 2006; 54(10)3306–9
   PubMedGoogle Scholar
• Lenton J, Donnelly R, Nash J R. Does temporal artery biopsy influence the management of temporal arteritis?. Qjm 2006; 99: 33–6
   PubMed Web of Science ®Google Scholar
• Macrae M, Tey A. Temporal artery biopsy in ophthalmology: a useful investigation. Qjm 2006; 99(5)350
   Google Scholar
• Mahr A, Saba M, Kambaouchner M, Polivka M, Baudrimont M, Brocheriou I, Coste J, Guilevin L. Temporal artery biopsy for diagnosing giant cell arteritis: the longer, the better?. Ann Rheum Dis 2006; 65: 826–8
   PubMed Web of Science ®Google Scholar
• Martinez-Taboada V M, Blanco R, Armona J, Uriarte E, Figueroa M, Gonzalez-Gay M A, Rodriguez-Valverde V. Giant cell arteritis with an erythrocyte sedimentation rate lower than 50. Clin Rheumatol 2000; 19: 73–5
   PubMed Web of Science ®Google Scholar
• Martinez-Taboada V, Brack A, Hunder G G, Goronzy J J, Weyand C M. The inflammatory infiltrate in giant cell arteritis selects against B lymphocytes. J Rheumatol 1997; 23(6)1011–4
   Google Scholar
• Mattey D L, Hajeer A H, Dababneh A, Thomson W, Gonzalez-Gay M A, Garcia-Porrua C, Ollier W E. Association of giant cell arteritis and polymyalgia rheumatica with different tumor necrosis factor microsatellite polymorphisms. Arthritis Rheum 2000; 43(8)1749–55
   Google Scholar
• Mazlumzadeh M, Hunder G G, Easley K A, Calamia K T, Matteson E L, Griffing W L, Younge B R, Weyand C M, Goronzy J J. Treatment of giang cell arteritis using induction therapy with high-dose glucocorticoids: a doule-blind, placebo-controlled, randomized prospective clinical trial. Arthritis Rheum 2006; 54(10)3310–8
   PubMed Web of Science ®Google Scholar
• Meroni P L, Raschi E, Testoni C, Tincani A, Balestrieri G, Molteni R, et al. Statins prevent endothelial cell activation induced by antiphospholipid (anti-ÿ-glycoprotein I) antibodies: effect on the proadhesive and proinflammatory phenotype. Arthritis Rheum 2001; 44: 2870–8
   PubMed Web of Science ®Google Scholar
• Narvaez J, Bernad B, Nolla J M, Valverde J. Statin therapy does not seem to benefit giant cell arteritis. Semin Arthritis Rheum 2007; 36(5)322–7
   PubMed Web of Science ®Google Scholar
• Nesher G, Berkun Y, Mates M, Baras M, Rubinow A, Sonnenblick M. Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis. Arthritis Rheum 2004; 50(4)1332–7
   PubMedGoogle Scholar
• Paget S A, Leibowitz E. Giant Cell Arteritis. February, 2006, E-medicine.com
   Google Scholar
• Parikh M, Miller N R, Lee A G, Savino P J, Vacarezza M N, Cornblath W, Eggenberger E, Antonio-Santos A, Golnik K, Kardon R, Wall M. Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis. Ophthalmology 2006; 113(10)1842–5
   PubMed Web of Science ®Google Scholar
• Park J R, Jones J G, Hazleman B L. Relationship of the erythrocyte sedimentation rate to acute phase proteins in polymyalgia rheumatica and giant cell arteritis. Ann Rheum Dis 1981; 40(5)493–5
   Google Scholar
• Pfadenhauer K, Weber H. Duplex sonography of the temporal and occipital artery in the diagnosis of temporal arteritis. A prospective study. J Rheumatol 2003; 30: 2177–81
   PubMed Web of Science ®Google Scholar
• Ponge T, Barrier J H, Grolleau J, Ponge A, Vlasak A, Cottin S. The efficacy of selective unilateral temporal artery biopsy versus bilateral biopsies for diagnosis of giant cell arteritis. J Rheum 1988; 15: 997–1000
   PubMedGoogle Scholar
• Powers J F, Bedri S, Hussein S, Salomon R N, Tischler A S. High prevalence of herpes simplex virus DNA in temporal arteritis biopsy specimens. Am J Clin Pathol 2005; 123: 261–4
   PubMed Web of Science ®Google Scholar
• Proven A, Gabriel S E, Orces C, O'Fallon M, Hunder G G. Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes. Arthritis Rheum 2003; 49(5)703–8
   PubMed Web of Science ®Google Scholar
• Rimar D, Rozenbaum M, Zisman D, Boulman N, Slobodin G, Eder L, Feld J, Rosner I. Giant cell arteritis–the methotrexate debate revisited. J Rheumatology 2006; 33(7)1458–9
   Google Scholar
• Rodriguez-Pla A, Bosch-Gil J A, Rossello-Urgell J, Huguet-Redecilla P, Stone J H, Vilardell-Tarres M. Metalloproteinase-2 and-9 in giant cell arteritis: involvement in vascular remodeling. Circulation 2005; 112: 264–9
   PubMed Web of Science ®Google Scholar
• Rodriguez-Pla A, Rossello-Urgell J, Bosch-Gil J A, Huguet-Redecilla P, Vilardell-Tarres M. Proposal to decrease the number of negative temporal artery biopsies. Scand J Rheumatol 2007; 36(2)111–8
   PubMed Web of Science ®Google Scholar
• Roque M R, Roque B L, Miserocchi E, et al. Giant Cell arteritis. January, 2006, E-medicine.com
   Google Scholar
• Salvarani C, Cantini F, Boiardi L, Hunder G G. Polymyalgia Rheumatica and Giant-Cell Arteritis. The New England Journal of Medicine 2002; 347(4)261–271
   PubMed Web of Science ®Google Scholar
• Salvarani C, Cantini F, Boiardi L, Hunder G G. Laboratory investigations useful in giant cell arteritis and Takayasu's arteritis. Clin Exp Rheumatol 2003; 21: S23–8, (Suppl 32)
   Web of Science ®Google Scholar
• Salvarani C, Farnetti E, Casali B, Nicoli D, Wenlan L, Bajocchi G, Macchioni P, Lo Scocco G, Catanoso M G, Boiardi L. Detection of parvovirus B19 DNA by polymerase chain reaction in giant cell arteritis: a case-control study. Arthritis Rheum 2002; 46(11)3099–3101
   Google Scholar
• Salvarani C, Hunder G G. Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurrence in a population-based study. Arthritis Rheum 2001; 45(2)140–5
   Google Scholar
• Salvarani C, Silingardi M, Ghirarduzzi A, Lo Scocco G, Macchioni P, Bajocchi G, Vinceti M, Cantini F, Iori I, Boiardi L. Is duplex ultrasonography useful for the diagnosis of giant-cell arteritis?. Ann Intern Med 2002; 137: 232–8
   PubMed Web of Science ®Google Scholar
• Schmidt W A, Blockmans D. Use of ultrasonography and positron emission tomography in the diagnosis and assessment of large-vessel vasculitis. Curr Opin Rheumatol 2004; 17: 9–15
   Google Scholar
• Schmidt W A, Kraft H E, Vorpahl K, Volker L, Gromnica-Ihle G. Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med 1997; 337: 1336–42
   PubMed Web of Science ®Google Scholar
• Seton M. Giant cell arteritis in a patient taking etanercept and methotrexate. J Rheumatology 2004; 31(7)1467
   PubMed Web of Science ®Google Scholar
• Smetana G W, Shmerling R H. Does this patient have temporal arteritis?. JAMA 2002; 287: 92–101
   PubMed Web of Science ®Google Scholar
• Spiera R F, Mitnick H J, Kupersmith M, Richmond M, Spiera H, Peterson M G, Paget S A. A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA). Clin Exp Rheum 2001; 19(5)495–501
   PubMed Web of Science ®Google Scholar
• Spiera R F, Spiera H. Therapy for giant cell arteritis: can we do better?. Arthritis Rheum 2006; 54(10)3071–4
   Google Scholar
• Van d er, Veen M J, Dinant H J, van Booma-Frankfort C, van Albada-Kuipers G A, Bijlsma J W. Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?. Ann Rheum Dis 1996; 55(4)218–23
   Google Scholar
• Weyand C M, Fulbright J W, Hunder G G, Evans J M, Goronzy J J. Treatment of giant cell arteritis: Interleukin-6 as a biologic marker of disease activity. Arthritis Rheum 2000; 43(5)1041–8
   PubMed Web of Science ®Google Scholar
• Weyand C M, Goronzy J J. Arterial wall injury in giant cell arteritis. Arthritis Rheum 1999; 42(5)844–53
   PubMedGoogle Scholar
• Weyand C M, Hicok K C, Hunder G G, Goronzy J J. Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis. Annals Int Med 1994; 121(7)484–91
   PubMed Web of Science ®Google Scholar
• Weyand C M, Kaiser M, Yang H, Younge B, Goronzy J J. Therapeutic effects of acetylsalicylic acid in giant cell arteritis. Arthritis Rheum 2002; 46(2)457–66
   Google Scholar
• Wong R L, Korn J H. Temporal arteritis without an elevated erythrocyte sedimentation rate: case report and review of the literature. Am J Med 1986; 80: 959–64
   Google Scholar
• Younge B R, Cook B E, Bartley G B, Hodge D O, Hunder G G. Initiation of glucocorticoid therapy: before or after temporal artery biopsy?. Mayo Clin Proc 2004; 79: 483–91
   PubMed Web of Science ®Google Scholar
• Younger D S. Headaches and vasculitis. Neurol Clin N Am 2004; 22: 207–228
   Google Scholar